HOME >> MEDICINE >> NEWS
EDCTP welcomes G8 support for HIV/AIDS vaccine development

The Hague, the Netherlands On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and commitment to accelerating the research on and availability of a vaccine against HIV, one of the major impediments today to sustainable development of underprivileged countries.

The European and Developing Countries Clinical Trials Partnership (EDCTP) believes that critical impediments to development such as the ones inflicted by HIV/AIDS, must be addressed by having the Developing Countries benefit from both the tools resulting from research (based on their public health needs), and the systems which they have acquired to assess those tools independently.

The renewed emphasis about HIV expressed by the G8 Leaders is welcome, timely and only too needed. At the same time, we must not forget that the same challenges are being faced with tuberculosis and malaria, as well as other, more neglected causes of illness and poverty in the developing world. The EDCTP strongly believes that ultimately the outcome of this initiative and others will depend on the ownership and commitment to this vision by the partners, and by having the concerned countries play a central role.

Adapted interventions are essential to reduce the burden caused by these diseases. Current approaches to vaccine development suffer from common problems and shortcomings, which are shared by all of these diseases. The EDCTP believes that a common, coordinated approach will benefit and expedite developments in general (i.e. capacities and methodologies).

There are today insufficient capacities and overall capabilities to test products clinically in high-burden countries. The EDCTP upholds high scientific and ethic
'"/>

Contact: Sandor Vrij
vry@edctp.org
31-70-344-0885
Netherlands Organization for Scientific Research
11-Jun-2004


Page: 1 2

Related medicine news :

1. Media invitation first annual EDCTP Forum
2. South African MRC hosts the African branch office of EDCTP Secretariat
3. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
4. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
5. Emergency department study supports giving dehydrated children fluids by mouth
6. Early supported discharge services can reduce long term dependency for stroke patients
7. Care of rural stroke patients improves with telephone support
8. Review supports link between HRT and stroke
9. Chamomile tea: New evidence supports health benefits
10. Psychological support helps adolescents with chronic fatigue syndrome
11. Social supports lessen effects of maltreatment on children vulnerable to depression

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EDCTP welcomes support for HIV AIDS vaccine development

(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... Pediatrician-in-Chief Jon McCullers, MD, was recently invited to ... Nature Reviews Microbiology , one of the ... world-renowned infectious disease specialist, and chair of the ... Health Science Center, analyzed the epidemiology and microbiology ... pandemics, as well as more recent 2009 novel ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
(Date:4/17/2014)... IL, April 17, 2014-- Colic affects about one in ... for numerous pediatric visits during the first several months ... colic symptoms was showing promise; however, the April 1, ... (BMJ2014;348:g2107; Sung, Valerie) reported on a study, "Probiotics and ... L reuteri for infant colic did ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
(Date:1/15/2014)... Jan. 15, 2014  A novel wearable injector slightly larger than ... for patients to self-inject prescription drugs in the large doses ... blood diseases, autoimmune deficiencies, and genetic disorders.  ... $220B by 2018, according to analysts.   Many of these drugs ...
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
Cached News: